The role of Hyaluronan-triggering epithelial to mesenchymal transition on multidrug resistance in malignant mesohtlioma cells.
Project/Area Number |
22700889
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Tumor biology
|
Research Institution | Hyogo University of Health Sciences |
Principal Investigator |
OHNO Yoshiya 兵庫医療大学, 薬学部, 助教 (40509155)
|
Project Period (FY) |
2010 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 癌 / ヒアルロン酸 / 接着分子 / 上皮間葉転換 |
Research Abstract |
Low intermediate molecular weight hyaluronan(HA) triggered epithelial-to-mesenchymal transition(EMT) and enhanced chemoresistance in malignant mesothelioma cells. Additionally, chemosensitivy of mesothelioma cells were resulted in a slight improvement by blocking of HA-CD44 signaling. Subpopulation equipped with cancer stem cells(CSCs)-associated properties were founded in mesothelioma spheroids expressing EMT markers. CSC-like subpopulation showed up-regulation of hyaluronan synthases(HAS) and were suppressed in the presence of hyaluronan synthases inhibitor, 4-methylumbelliferone(4MU). These results suggested that hyaluronan mediated regulation of EMT-and CSCs-properties related with chemoresistance on malignant mesothelioma cells.
|
Report
(3 results)
Research Products
(11 results)
-
[Journal Article] Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cells2012
Author(s)
Masuko. K, Okazaki S., Satoh M., Tanaka G., Ikeda T., Torii R., Ueda E., Nakano T., Danbayashi M., Tsuruoka T., Ohno Y., Yagi H., Yabe N., Yoshida H., Tahara T., Kataoka S., Oshino T., Shindo T., Niwa S., Ishimoto T., Baba H., Hashimoto Y., Saya H. & Masu
-
Journal Title
Related Report
Peer Reviewed
-
-
[Journal Article] NIH3T3 cells overexpressing CD98 heavy chain resist early G1 arrest andapoptosis induced by serum starvation.2012
Author(s)
Hara K, Ueda S, Ohno Y, Tanaka T, Yagi H, Okazaki S, Kawahara R, Masayuki T, Enomoto T, Hashimoto Y, Masuko K, Masuko T.
-
Journal Title
Cancer Sci
Volume: 103
Issue: 8
Pages: 1460-1466
DOI
Related Report
Peer Reviewed
-
[Journal Article] Oncogenicity of L-type amino-acid transporter 1(LAT1) revealed by targeted gene disruption in chicken DT40 cells : LAT1 is a promising molecular target for human cancer therapy2011
Author(s)
Ohkawa M., Ohno, Y., Masuko K., Takeuchi A., Suda K., Kubo A., Kawahara R., Okazaki S., Tanaka T., Saya H., Seki M., Enomoto T., Yagi H., Hashimoto Y. & Masuko T.
-
Journal Title
Biochem. Biophys. Res. Commun
Volume: 406
Pages: 649-655
Related Report
Peer Reviewed
-
-
[Journal Article] Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells : LAT1 is a promising molecular target for human cancer therapy2011
Author(s)
Ohkawa, M., Ohno, Y., Masuko, K., Takeuchi, A., Suda, K., Kubo, A., Kawahara, R., Okazaki, S., Tanaka, T., Saya, H., Seki, M., Enomoto, T., Yagi, H., Hashimoto, Y., Masuko, T.
-
Journal Title
Biochem.Biophys.Res.Commun.
Volume: 406
Issue: 4
Pages: 649-655
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] NIH3T3 cells over-expressing CD98 heavy chain resist early G1 arrest and apoptosis induced by serum starvation
Author(s)
Hara K., Ueda S., Ohno Y., Tanaka T., Yagi H., Okazaki S., Kawahara R., Masayuki T., Enomoto T., Hashimoto Y., Masuko K. & Masuko T
-
Journal Title
Cancer Sci
Volume: (in press)
Related Report
Peer Reviewed
-
-
-